Head of Technology Platform

Company Summary:

Quotient Therapeutics, Inc. is a privately held, early-stage company developing a novel genomics platform and therapeutics for diseases with a large unmet need.

Quotient Therapeutics, Inc. was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Seres Therapeutics (NASDAQ: MCRB), Sana Biotechnology (SANA), Axcella Health (AXLA), Indigo Agriculture, Generate Biomedicines, and Tessera Therapeutics.

Position Summary:

We are seeking a Head of Platform that reports to the Chief Science Officer (CSO) and leads a team of scientists. The role involves leadership over Quotient’s lab-based genomics platform, covering the breadth of the development of new experimental capabilities to implementation of high-throughput approaches that maximize operational efficiency and output. Our ideal candidate is someone who thinks strategically, and constantly questions the status quo in search of cutting edge methods and accelerated experimental timelines. The ideal candidate has strong leadership experience, able to lead a diverse team at different levels of seniority. Being collaborative is key – this leader will need to engage and integrate across other teams at Quotient, such as in data science, and target discovery science. This role is based in the vicinity of Cambridge UK and will be primarily based on site. All applicants will require permission to work in the UK.

Key Responsibilities:

• Lead Quotient’s platform technology group, which includes the search and implementation of new technologies, implementation of high-throughput methods, and maximizing data generation throughput and reliability
• Drive the operations of our genomics pipeline, delivering upon the core Somatic Genomics projects at the heart of Quotient’s proprietary target discovery approach
• Lead and manage multiple teams of lab-based scientists, who are responsible for technology development, implementation and operation
• Constantly question the status quo, driving towards cutting-edge solutions in terms of new technologies and operational excellence
• Work directly with the CSO to drive towards major corporate goals, leading Quotient’s technological vision
• Set a high bar for innovation and operations, aiming for rigorous quality
• Collaborate with other leaders at Quotient, constantly seeking ways to innovate and optimize 

Qualifications:

• Ph.D. in biology or related discipline with 12+ years of relevant post-Ph.D. experience with an excellent track record of discovering therapeutic targets in a variety of diseases
• Experience developing cutting edge genomics methods, and scaling up for high-throughput data generation, including through the use of automation
• Experience overseeing laboratory operations, with proven track record of operational excellence and knowledge of continuous improvement methods
• Team leadership experience, overseeing team members at different levels of seniority
• Strong written and verbal communication, capable of communicating complex datasets to internal and external stakeholders
• Prior experience developing, owning and delivering visionary technology strategies

About Flagship

Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.  Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.